Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET known ✓ | P08581 | 1/20 | 0.46 |
| ▸ | GLA known ✓ | P06280 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | SLC9A1 | P19634 | 7/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.46 |
| ▸ | EGLN3 | Q9H6Z9 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3428426 | 0.81 | NPC1 (1.00) | NPC1MAPTRAB9ASLC9A1GRM2 | |
| SCHEMBL2595317 | 0.73 | SLC9A1 (0.65) | ALDH1A1KDM4ENPC1MAPTRAB9A | |
| SCHEMBL9911119 | 0.73 | ALDH1A1 (0.61) | ALDH1A1KDM4EMAPTSLC9A1GRM2 | |
| SCHEMBL19327451 | 0.72 | HTT (0.69) | ALDH1A1KDM4EMETEGLN3 | |
| SCHEMBL30701749 | 0.69 | ALDH1A1 (0.56) | ALDH1A1KDM4ENPC1MAPTRAB9A | |
| SCHEMBL16036548 | 0.68 | ALDH1A1 (1.00) | ALDH1A1KDM4ENPC1RAB9AMET | |
| SCHEMBL20817973 | 0.67 | ALDH1A1 (0.60) | ALDH1A1KDM4ESLC9A1GRM2MET | |
| SCHEMBL20831331 | 0.67 | ALDH1A1 (0.60) | ALDH1A1KDM4ESLC9A1GRM2MET | |
| SCHEMBL14027557 | 0.67 | LTA4H (0.62) | ALDH1A1KDM4EMETTSHR | |
| SCHEMBL6805526 | 0.67 | MAPT (0.70) | KDM4ENPC1MAPTRAB9ASLC9A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117025657-A | Efficient gene editing tool for Antarctic morganella and application thereof | 中国农业科学院麻类研究所 | 2023-11-10 | — | — | CN | claimed |
| CN-122029972-A | Display device | 三星显示有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12591804-B2 | Systems and methods for distributed learning for wireless edge dynamics | INTEL CORPORATION (US) | 2026-03-31 | — | — | US | disclosed |
| US-20250126996-A1 | DISPLAY APPARATUS | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-04-17 | — | — | US | disclosed |
| WO-2025080041-A1 | DISPLAY DEVICE | 삼성디스플레이주식회사 | 2025-04-17 | — | — | WO | disclosed |
| CN-119144595-B | Tyrosine decarboxylase mutant and application thereof in fermentation synthesis of 3-amino-1-propanol | 中国科学院微生物研究所 | 2025-02-14 | — | — | CN | disclosed |
| CN-119230109-A | System, method and device for evaluating immune health | 中国医学科学院肿瘤医院 | 2024-12-31 | — | — | CN | disclosed |
| CN-119144595-A | Tyrosine decarboxylase mutant and application thereof in fermentation synthesis of 3-amino-1-propanol | 中国科学院微生物研究所 | 2024-12-17 | — | — | CN | disclosed |
| EP-3548096-B1 | INHIBITOR-FUNCTIONALIZED ULTRASMALL NANOPARTICLES AND METHODS THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-117778431-A | Plasmid system for packaging recombinant adeno-associated virus and application thereof | 广州派真生物技术有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117025657-A | Efficient gene editing tool for Antarctic morganella and application thereof | 中国农业科学院麻类研究所 | 2023-11-10 | — | — | CN | disclosed |
| US-11660354-B2 | Inhibitor-functionalized ultrasmall nanoparticles and methods thereof | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-05-30 | — | — | US | disclosed |
| US-11653686-B2 | Steviol glycoside compositions | PURECIRCLE USA INC. (US) | 2023-05-23 | — | — | US | disclosed |
| US-11607461-B2 | Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-03-21 | — | — | US | disclosed |
| CN-113201466-B | Saccharomyces cerevisiae engineering bacteria and application thereof in preparation of protocatechuic acid | 天津大学 | 2023-03-21 | — | — | CN | disclosed |
| US-20230068386-A1 | SYSTEMS AND METHODS FOR DISTRIBUTED LEARNING FOR WIRELESS EDGE DYNAMICS | INTEL CORPORATION (US) | 2023-03-02 | — | — | US | disclosed |
| EP-4100892-A1 | SYSTEMS AND METHODS FOR DISTRIBUTED LEARNING FOR WIRELESS EDGE DYNAMICS | Intel Corporation (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-114930347-A | System and method for distributed learning of wireless edge dynamics | 英特尔公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-113256066-B | PCA-XGboost-IRF-based job shop real-time scheduling method | 新疆大学 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12591804-B2 | Systems and methods for distributed learning for wireless edge dynamics | TPRKB, KCNE1, GRIK1 | MET 4667/4885GLA 3323/4885ALDH1A1 4796/4885 |
| US-11660354-B2 | Inhibitor-functionalized ultrasmall nanoparticles and methods thereof | GRPR, GIPR, PSMA1 | MET 109/4885GLA 1027/4885ALDH1A1 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.